- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04908501
Health Care Appropriateness Assessment and Support Programme at a University Hospital Centre (CHU) in Bordeaux (sPREAdPerti)
Non-appropriateness of care is a common and serious phenomenon that affects healthcare institutions in France. Appropriateness in health care is about adequacy of any type of health care with patient's needs. Relying on structuring innovative tools, the hospital university centre of Bordeaux is implementing a health care appropriateness assessment and support programme ("sPREAd pertinence").
By using a mixed method, the project's main objective is to evaluate programme effectiveness on the improvement of care appropriateness in hospital university centre of Bordeaux. Other assessments are considering impact on: specific care appropriateness indicators, care related adverse events frequency, organizational climate, and work life satisfaction. The economic impact of this program in terms of induced costs and avoided costs will be evaluated. A qualitative approach will be used to identify the programme transferability conditions with a view to produce an Operational Model for the Implementation of Appropriateness at a Healthcare Institution.
Study Overview
Detailed Description
Non-appropriateness of care is a common and serious phenomenon that affects healthcare institutions in France. Appropriateness in health care is about adequacy of any type of health care with patient's needs. It means that a health care is necessary and relevant, given a specific indication, with regard to updated practice recommendations or justifications of experts.
The hospital university centre of Bordeaux is making Health care appropriateness a policy priority. Relying on structuring innovative tools, it is implementing a health care appropriateness assessment and support programme ("sPREAd pertinence"). This programme comprises two parts, one regarding interventional aspects and the other concerning assessments.
sPREAd-Pertinence programme's objectives Project's primary objective is to evaluate programme effectiveness on the improvement of care appropriateness in hospital university centre of Bordeaux.
Project's secondary objectives are :
- to assess impact on specific care appropriateness indicators, care related adverse events frequency, organizational climate and work life satisfaction.
- to evaluate the actual use of GAP.
- to measure the costs of implementing the sPREAD Perti program and to identify the additional costs incurred in comparison with the mobilization and support approach to care appropriateness already existing at the Bordeaux University Hospital;
- to compare the costs of the program with the consequences observed in terms of specific care appropriateness improvement, changes in serious adverse events frequency, organizational work climate and work life satisfaction;
- to estimate, if necessary, in terms of avoided costs, the reduction of serious adverse events frequency.
to identify, using a qualitative approach:
- The determinants of programme acceptability and efficiency
- The appropriation by professionals of the mobilization and support program
- The impact of the program on professional practices: changes in practices and perceived effectiveness
- The conditions for programme transferability with a view to producing an Operational Model for the Implementation of Appropriateness at a Healthcare Institution Study design The project is based on a mixed method approach. Study design for the quantitative part is a Stepped-Wedge cluster randomized controlled trial, completed by a control group not receiving the intervention. The clusters are the clinical services of the Bordeaux University Hospital. Up to six volunteer clinical services will be randomly selected to determine the order in which they will start the implementation of the intervention. A control group will be made up of clinical services that meet the inclusion criteria and do not belong to the group of six participating services. The control group will receive the usual support for improving the appropriateness of care.
Qualitative section of the project will analyse the mechanisms of program effectiveness using an exploratory approach based on semi-structured interviews and direct observations of PAG.
Global proportion of patient stays appropriate regarding health cares concerned with feedback indicators available at the start of the trial.
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Contact
- Name: Florence SAILLOUR-GLENISSON, Dr
- Phone Number: 05 57 57 46 40
- Email: florence.saillour@chu-bordeaux.fr
Study Locations
-
-
-
Bordeaux, France
- Recruiting
- CHU de Bordeaux
-
Contact:
- Florence SAILLOUR, Dr
- Phone Number: 05 57 57 46 40
- Email: florence.saillour@chu-bordeaux.fr
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Services: services of the non-transversal clinical departments of the Bordeaux University Hospital.
- Health professionals: Medical and paramedical professionals working during the day or night in the participating services for at least one month and at least one day per week.
- Patients: Stays of patients hospitalized at the Bordeaux University Hospital benefiting from care targeted by the automated indicators and made available by the feedback system at the start of the trial.
Exclusion Criteria:
- Services of the transversal and medico-technical departments (Medical Imaging department, Biology and Pathology department, Health Products department, Public Health department and Anesthesia-Intensive care department) and department with specific activity.
- Professionals: planning to be absent during the data collection period.
- Patients: none
Study Plan
How is the study designed?
Design Details
- Observational Models: Other
- Time Perspectives: Retrospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Intervention group
Services of the non-transversal clinical departments of the Bordeaux University Hospital willing to participate to the programme.
|
The program intervention has three focuses : the prioritization of appropriateness indicators, the automation and visualization of the prioritized indicators, and support for practice analysis groups (PAG) based on e-feedback from automated indicators
|
Control group
Services of the non-transversal clinical departments of the Bordeaux University Hospital not willing to participate to the programme.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Global proportion of patient stays appropriate regarding health cares concerned with feedback indicators available at the start of the trial.
Time Frame: Primary outcome is assessed 14 months after the start of the intervention
|
This proportion is calculated by dividing the number of appropriate patient stays for all indicators corresponding to targeted health care by the number of patients who received targeted health care for at least one of the indicators.
|
Primary outcome is assessed 14 months after the start of the intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Appropriate stays proportion specific to each feedback indicator available at the start of the trial
Time Frame: two months before and fourteen months after applying the programme in the first cluster.
|
Appropriate stays proportion specific to each feedback indicator available at the start of the trial is calculated as the number of stays appropriate according to the indicator (numerator) over the number of stays concerned by the indicator (denominator);
|
two months before and fourteen months after applying the programme in the first cluster.
|
Incidence density of serious adverse events
Time Frame: two months before and fourteen months after applying the programme in the first cluster.
|
Incidence density of serious adverse events measured by a specific data collection in each service using the questionnaires tested in the two France National Surveys on Adverse Events in Healthcare (ENEIS 1 and ENEIS 2);
|
two months before and fourteen months after applying the programme in the first cluster.
|
Dimension Scores of the Comet questionnaire
Time Frame: two months before and fourteen months after applying the programme in the first cluster.
|
Dimension Scores of the Comet ("Contexte Organisationnel et Managérial en Etablissement de santé" / Organizational and Managerial Context in Healthcare Establishments) questionnaire measuring the Organizational Climate (for each dimension, proportion of professionals giving the answers "completely agree" or "agree");
|
two months before and fourteen months after applying the programme in the first cluster.
|
Work life satisfaction
Time Frame: two months before and fourteen months after applying the programme in the first cluster.
|
Work life satisfaction score measured by the validated ESVP ("Echelle de Satisfaction globale de Vie Professionnelle" / global professional life satisfaction scale) questionnaire.
It consists of 5 items and assesses the overall satisfaction of individuals with their work life.
This score is calculated by summing the responses to each of the 5 items.
The answers materialize a position on a scale of agreement going from "1" (Not at all in agreement) to "7" (Totally in agreement).
The possible range of scores on this scale can thus oscillate from 5 (low satisfaction) to 35 (high satisfaction).
The higher the score, the greater the perceived satisfaction with work life.
|
two months before and fourteen months after applying the programme in the first cluster.
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- CHUBX 2019/65
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Any Conditions
-
BioSerenityUnknownHealthy Volunteers Without Any Cardiac or Any Neurological DisordersFrance
-
University of PittsburghCompleted
-
University Hospital Southampton NHS Foundation...WithdrawnAny Symptoms Requiring ColonoscopyUnited Kingdom
-
Universidad Miguel Hernandez de ElcheFundación para el Fomento de la Investigación Sanitaria y Biomédica de la...Completed
-
European Organisation for Research and Treatment...ETOP IBCSG Partners FoundationCompletedSPECTAlung: Screening Patients With Thoracic Tumors for Efficient Clinical Trial Access (SPECTAlung)Any Stage of Lung Cancer (Any Histotype) | Any Stage of Malignant Pleural Mesothelioma | Any Stage of Any Thymic MalignancySpain, Belgium, Ireland, Slovenia, France, United Kingdom, Poland, Italy, Switzerland
-
Gustave Roussy, Cancer Campus, Grand ParisUnknownMetastatic Solid Tumors (Any Localization)France
-
VasoNova, Inc.CompletedAny Condition Requiring a PICC PlacementUnited States
-
Johns Hopkins UniversityTerminatedFluid Resuscitation | Burn Any Degree Involving 20-29 Percent of Body Surface | Burn Any Degree Involving 30-39 Percent of Body Surface | Burn Any Degree Involving 40-49 Percent of Body Surface | Burn Any Degree Involving 50-59 Percent of Body Surface | Burn Any Degree Involving 60-65 Percent...United States
-
Vrije Universiteit BrusselUniversity of British Columbia; University of Coimbra; Amsterdam UMC, location... and other collaboratorsNot yet recruitingCancer (Active Cancer, Meaning Not Being Cancer Free), of Any Stage and Involving Any Treatment/Care Regimen; i.e. Curative, Life-extending, or Palliative
-
Hartford HospitalUnknownImplanted With Any Currently (and Any Future) FDA-approved Medtronic ICD or CRT Device | to Which is Attached a St. Jude Riata LeadUnited States
Clinical Trials on Intervention
-
Biolux Research Holdings, Inc.TerminatedOrthodontic Tooth MovementCanada
-
University of California, San FranciscoNational Cancer Institute (NCI)CompletedColorectal Carcinoma | Healthy Subject | Health Status UnknownUnited States
-
University of FloridaCompletedSensitivityUnited States
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI); National Institute on Minority Health and...RecruitingHuman Papillomavirus InfectionUnited States
-
Ohio State University Comprehensive Cancer CenterCompleted
-
Mayo ClinicNational Cancer Institute (NCI)WithdrawnCancer Survivor | Peripheral Sensory Neuropathy
-
Nottingham Trent UniversityUnknownOverweight and ObesityUnited Kingdom
-
OHSU Knight Cancer InstituteOregon Health and Science UniversityRecruitingAnatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage IA Breast Cancer AJCC v8 | Anatomic Stage IB Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIA Breast Cancer AJCC v8 | Anatomic Stage IIB Breast Cancer AJCC v8 | Anatomic Stage IIIA Breast Cancer AJCC v8 | Prognostic... and other conditionsUnited States
-
Sidney Kimmel Cancer Center at Thomas Jefferson...American Cancer Society, Inc.Completed
-
Vanderbilt UniversityAgency for Healthcare Research and Quality (AHRQ)Completed